359 related articles for article (PubMed ID: 15297674)
1. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography.
Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH
Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674
[TBL] [Abstract][Full Text] [Related]
2. Much anticipated--the bioactive conformation of epothilone and its binding to tubulin.
Heinz DW; Schubert WD; Höfle G
Angew Chem Int Ed Engl; 2005 Feb; 44(9):1298-301. PubMed ID: 15714588
[No Abstract] [Full Text] [Related]
3. Computational study of binding of epothilone A to β-tubulin.
Kamel K; Kolinski A
Acta Biochim Pol; 2011; 58(2):255-60. PubMed ID: 21633729
[TBL] [Abstract][Full Text] [Related]
4. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies.
Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M
FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461
[TBL] [Abstract][Full Text] [Related]
5. Comparative binding energy (COMBINE) analysis supports a proposal for the binding mode of epothilones to β-tubulin.
Coderch C; Klett J; Morreale A; Fernando Díaz J; Gago F
ChemMedChem; 2012 May; 7(5):836-43. PubMed ID: 22431398
[TBL] [Abstract][Full Text] [Related]
6. The high-resolution solution structure of epothilone A bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents.
Carlomagno T; Blommers MJ; Meiler J; Jahnke W; Schupp T; Petersen F; Schinzer D; Altmann KH; Griesinger C
Angew Chem Int Ed Engl; 2003 Jun; 42(22):2511-5. PubMed ID: 12800173
[No Abstract] [Full Text] [Related]
7. Structure of tubulin at 6.5 A and location of the taxol-binding site.
Nogales E; Wolf SG; Khan IA; Ludueña RF; Downing KH
Nature; 1995 Jun; 375(6530):424-7. PubMed ID: 7760939
[TBL] [Abstract][Full Text] [Related]
8. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide.
Sánchez-Pedregal VM; Kubicek K; Meiler J; Lyothier I; Paterson I; Carlomagno T
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7388-94. PubMed ID: 17036370
[No Abstract] [Full Text] [Related]
9. The binding mode of side chain- and C3-modified epothilones to tubulin.
Erdélyi M; Navarro-Vázquez A; Pfeiffer B; Kuzniewski CN; Felser A; Widmer T; Gertsch J; Pera B; Díaz JF; Altmann KH; Carlomagno T
ChemMedChem; 2010 Jun; 5(6):911-20. PubMed ID: 20432490
[TBL] [Abstract][Full Text] [Related]
10. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.
Snyder JP; Nettles JH; Cornett B; Downing KH; Nogales E
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5312-6. PubMed ID: 11309480
[TBL] [Abstract][Full Text] [Related]
11. Conformation-activity relationships in polyketide natural products: a new perspective on the rational design of epothilone analogues.
Taylor RE; Chen Y; Beatty A; Myles DC; Zhou Y
J Am Chem Soc; 2003 Jan; 125(1):26-7. PubMed ID: 12515494
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile.
Shi G; Wang Y; Jin Y; Chi S; Shi Q; Ge M; Wang S; Zhang X; Xu S
J Biomol Struct Dyn; 2012; 30(5):559-73. PubMed ID: 22731768
[TBL] [Abstract][Full Text] [Related]
13. Molecular recognition of epothilones by microtubules and tubulin dimers revealed by biochemical and NMR approaches.
Canales A; Nieto L; Rodríguez-Salarichs J; Sánchez-Murcia PA; Coderch C; Cortés-Cabrera A; Paterson I; Carlomagno T; Gago F; Andreu JM; Altmann KH; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2014 Apr; 9(4):1033-43. PubMed ID: 24524625
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling study on the tubulin-binding modes of epothilone derivatives: Insight into the structural basis for epothilones activity.
Jiménez VA; Alderete JB; Navarrete KR
Chem Biol Drug Des; 2017 Dec; 90(6):1247-1259. PubMed ID: 28632973
[TBL] [Abstract][Full Text] [Related]
15. Refined structure of alpha beta-tubulin at 3.5 A resolution.
Löwe J; Li H; Downing KH; Nogales E
J Mol Biol; 2001 Nov; 313(5):1045-57. PubMed ID: 11700061
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for drug resistance conferred by β-tubulin mutations: a molecular modeling study on native and mutated tubulin complexes with epothilone B.
Navarrete KR; Alderete JB; Jiménez VA
J Biomol Struct Dyn; 2015; 33(12):2530-40. PubMed ID: 26081685
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of novel epothilone analogues by means of a common pharmacophore and a QSAR pseudoreceptor model for taxanes and epothilones.
Forli S; Manetti F; Altmann KH; Botta M
ChemMedChem; 2010 Jan; 5(1):35-40. PubMed ID: 19904799
[No Abstract] [Full Text] [Related]
18. Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK.
Nagano S; Li H; Shimizu H; Nishida C; Ogura H; Ortiz de Montellano PR; Poulos TL
J Biol Chem; 2003 Nov; 278(45):44886-93. PubMed ID: 12933799
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the regulation of tubulin by vinblastine.
Gigant B; Wang C; Ravelli RB; Roussi F; Steinmetz MO; Curmi PA; Sobel A; Knossow M
Nature; 2005 May; 435(7041):519-22. PubMed ID: 15917812
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the Epothilone Binding Site on β-Tubulin by Photoaffinity Labeling: Identification of β-Tubulin Peptides TARGSQQY and TSRGSQQY as Targets of an Epothilone Photoprobe for Polymerized Tubulin.
Ranade AR; Higgins L; Markowski TW; Glaser N; Kashin D; Bai R; Hong KH; Hamel E; Höfle G; Georg GI
J Med Chem; 2016 Apr; 59(7):3499-514. PubMed ID: 26986898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
